Oren Hershkovitz

Fortuna: 34 673 $ al 31/05/2024

47 años

Health Technology

Consumer Services

Cargos activos de Oren Hershkovitz

Empresas	Cargo	Inicio	Fin
ENLIVEX THERAPEUTICS LTD.	Director Ejecutivo	16/11/2019	-
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Director/Miembro de la Junta	01/09/2016	-

Ben-Gurion University of the Negev

Doctorate Degree

Internacional

Israel

Operativa

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
ENLIVEX THERAPEUTICS LTD.	Health Technology

Empresas privadas	1
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Health Technology

Empresas privadas

Health Technology